financetom
BTMD
financetom
/
Healthcare
/
BTMD
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
biote Corp.BTMD
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
Market Cap
132.52M
Revenue (ttm)
197.19M
Net Income (ttm)
3.16M
Shares Out
36.71M
EPS (ttm)
0.09
PE Ratio
37.11
Forward PE
8.35
Dividend
n/a
Ex-Dividend Date
n/a
Volume
121,343
Open
3.400
Previous Close
3.350
Day's Range
3.320 - 3.610
52-Week Range
3.040 - 8.440
Beta
1.18
Analysts
Strong Buy
Price Target
8.00 (+121.61%)
Earnings Date
May 6, 2025
Description >

biote Corp. operates in medical practice-building business within the hormone optimization space.

The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements.

It also sells Biote-branded dietary supplements; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female.

The company was founded in 2012 and is headquartered in Irvine, Texas.

Copyright 2023-2025 - www.financetom.com All Rights Reserved